Krystyna Lesiak

1.5k total citations
67 papers, 1.3k citations indexed

About

Krystyna Lesiak is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Krystyna Lesiak has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Organic Chemistry and 14 papers in Infectious Diseases. Recurrent topics in Krystyna Lesiak's work include DNA and Nucleic Acid Chemistry (24 papers), Biochemical and Molecular Research (14 papers) and HIV/AIDS drug development and treatment (14 papers). Krystyna Lesiak is often cited by papers focused on DNA and Nucleic Acid Chemistry (24 papers), Biochemical and Molecular Research (14 papers) and HIV/AIDS drug development and treatment (14 papers). Krystyna Lesiak collaborates with scholars based in United States, Poland and Belgium. Krystyna Lesiak's co-authors include Paul F. Torrence, Wojciech J. Stec, Junta Imai, Janina Baraniak, Hiroaki Sawai, Robert H. Silverman, Teréz Kovács, Jiro Imai, R. Kinas and Kyoichi A. Watanabe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Krystyna Lesiak

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krystyna Lesiak United States 23 865 315 304 179 101 67 1.3k
Alexander A. Krayevsky Russia 21 986 1.1× 473 1.5× 316 1.0× 140 0.8× 127 1.3× 89 1.3k
Keith Biggadike United Kingdom 19 621 0.7× 305 1.0× 605 2.0× 122 0.7× 67 0.7× 45 1.4k
Linda L. Wotring United States 22 632 0.7× 233 0.7× 684 2.3× 223 1.2× 65 0.6× 69 1.5k
Wallace T. Ashton United States 22 767 0.9× 226 0.7× 588 1.9× 430 2.4× 46 0.5× 59 1.8k
Dominique Deville‐Bonne France 24 950 1.1× 313 1.0× 176 0.6× 169 0.9× 157 1.6× 56 1.3k
Moon Woo Chun South Korea 21 750 0.9× 346 1.1× 763 2.5× 116 0.6× 48 0.5× 104 1.3k
Vincent S. Stoll United States 22 743 0.9× 194 0.6× 449 1.5× 288 1.6× 87 0.9× 49 1.5k
Alexander Hampton United States 21 987 1.1× 227 0.7× 421 1.4× 173 1.0× 35 0.3× 82 1.3k
Bruce S. Ross United States 17 762 0.9× 644 2.0× 351 1.2× 452 2.5× 70 0.7× 42 1.6k
Soo S. Ko United States 20 561 0.6× 169 0.5× 841 2.8× 80 0.4× 101 1.0× 32 1.5k

Countries citing papers authored by Krystyna Lesiak

Since Specialization
Citations

This map shows the geographic impact of Krystyna Lesiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystyna Lesiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystyna Lesiak more than expected).

Fields of papers citing papers by Krystyna Lesiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krystyna Lesiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystyna Lesiak. The network helps show where Krystyna Lesiak may publish in the future.

Co-authorship network of co-authors of Krystyna Lesiak

This figure shows the co-authorship network connecting the top 25 collaborators of Krystyna Lesiak. A scholar is included among the top collaborators of Krystyna Lesiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystyna Lesiak. Krystyna Lesiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lesiak, Krystyna, et al.. (1999). Synthesis of a Novel C-Nucleoside, 2-Amino-7-(2-deoxy-β- D-erythro-pentofuranosyl)-3H,5H-pyrrolo-[3,2-d]pyrimidin-4-one (2′-Deoxy-9-deazaguanosine). Nucleosides and Nucleotides. 18(3). 363–376. 11 indexed citations
2.
Brown, David A., et al.. (1998). Aliphatic and Alicyclic Diols Induce Melanogenesis in Cultured Cells and Guinea Pig Skin. Journal of Investigative Dermatology. 110(4). 428–437. 15 indexed citations
3.
Xiao, Wei, Mark R. Player, Guang Li, et al.. (1996). Synthesis and Characterization of Composite Nucleic Acids Containing 2‵,5‵-Oligoriboadenylate Linked to Antisense DNA. Antisense and Nucleic Acid Drug Development. 6(4). 247–258. 22 indexed citations
4.
Xiao, Wei, et al.. (1994). Synthesis of a 5′-thiophosphate analogue of 2-5A, a phosphatase resistant activator of the 2-5A-dependent ribonuclease. Bioorganic & Medicinal Chemistry Letters. 4(21). 2609–2614. 21 indexed citations
5.
Lesiak, Krystyna, et al.. (1993). 2',5'-Oligoadenylate:antisense chimeras. Synthesis and properties. Bioconjugate Chemistry. 4(6). 467–472. 33 indexed citations
6.
Torrence, Paul F., et al.. (1992). A new and potent 2-5A analogue which does not require a 5′-polyphosphate to activate mouse L-cell RNase L. Antiviral Research. 18(3-4). 275–289. 6 indexed citations
7.
Castora, Frank J., et al.. (1991). 2′,5′-01igoadenylates Inhibit Relaxation of Supercoiled DNA by Calf Thymus DNA Topoisomerase I. Journal of Interferon Research. 11(3). 143–149. 24 indexed citations
9.
Kovács, Teréz, et al.. (1990). Inhibition of the RNA polymerase of vesicular stomatitis virus by ppp5′A2′p5′A and related compounds. Antiviral Research. 13(2). 81–89. 5 indexed citations
10.
Lesiak, Krystyna, et al.. (1989). Conformational analysis of brominated pA2′‐5′A2′‐5′A analogs. European Journal of Biochemistry. 182(3). 629–637. 14 indexed citations
11.
Lesiak, Krystyna, Erik De Clercq, & Paul F. Torrence. (1989). Adducts of Mannose 6-Phosphate with 5-Iodo-2′-Deoxyuridine and 2-5A as Potential Antiviral Agents. Nucleosides and Nucleotides. 8(8). 1387–1398. 1 indexed citations
12.
Torrence, Paul F., Junei Kinjo, Krystyna Lesiak, Jan Balzarini, & Erik De Clercq. (1988). AIDS dementia: Synthesis and properties of a derivative of 3′‐azido‐3′‐deoxythymidine (AZT) that may become ‘locked’ in the central nervous system. FEBS Letters. 234(1). 135–140. 44 indexed citations
13.
Lesiak, Krystyna, et al.. (1986). Synthesis and biological activities of oligo(8-bromoadenylates) as analogs of 5'-O-triphosphoadenylyl(2'.fwdarw.5')adenylyl(2'.fwdarw.5')adenosine. Journal of Medicinal Chemistry. 29(6). 1015–1022. 28 indexed citations
14.
Torrence, Paul F., et al.. (1986). [70] Methods for the synthesis of analogs of (2′-5′)-oligoadenylic acid. Methods in enzymology on CD-ROM/Methods in enzymology. 119. 522–529. 3 indexed citations
16.
Torrence, Paul F., et al.. (1985). Sequence-specific 2'5'-oligonucleotides in the molecular dissection of the biological activity of 2-5A.. PubMed. 202. 75–80. 1 indexed citations
17.
Imai, Junta, et al.. (1982). Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.. PubMed. 97–100. 1 indexed citations
18.
Lesiak, Krystyna & Wojciech J. Stec. (1977). Synthesis Of Asymmetric S, S, S-Trialkyl Phosphorotrithioates. Synthetic Communications. 7(5). 339–344. 3 indexed citations
19.
Stec, Wojciech J., et al.. (1976). ChemInform Abstract: REACTION OF CARBONYL ISOTHIO(SELENO)CYANATES WITH TRIVALENT PHOSPHORUS ESTERS. Chemischer Informationsdienst. 7(11). 4 indexed citations
20.
Stec, Wojciech J., et al.. (1975). Assignment of cis-trans Geometry in Diastereomeric 2-Benzyl-4-methyl-1,3,2-dioxaphosphorinans and their 2-Oxo- and 2-Seleno-Derivatives. Zeitschrift für Naturforschung B. 30(9-10). 710–715. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026